Idexx Laboratories (IDXX) Shares Outstanding (2009 - 2026)

Idexx Laboratories' Shares Outstanding (Entity) history runs 18 years deep, the most recent figure standing at $79.6 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Entity) fell 2.05% year-over-year to $79.6 million; the TTM figure through Mar 2026 stood at $79.6 million (down 2.05% YoY), while the FY2025 annual figure was $80.4 million, down 2.47% from the prior year.
• Shares Outstanding (Entity) for Q1 2026 stood at $79.6 million, down from $80.4 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $84.4 million in Q1 2022, with the low at $79.6 million in Q1 2026.
• The 5-year median for Shares Outstanding (Entity) is $83.0 million (2023), against an average of $82.3 million.
• The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Entity) grew 0.13% in 2024, then fell 2.68% in 2025.
• Idexx Laboratories' Shares Outstanding (Entity) stood at $83.6 million in 2022, then slipped by 0.67% to $83.1 million in 2023, then declined by 0.72% to $82.5 million in 2024, then retreated by 2.47% to $80.4 million in 2025, then declined by 0.97% to $79.6 million in 2026.
• Business Quant data shows IDXX's Shares Outstanding (Entity) at $79.6 million in Q1 2026, $80.4 million in Q4 2025, and $80.1 million in Q3 2025.